This post first appeared on East Midlands Business Link. Read the original article.
Oncimmune Holdings, the Nottingham-based immunodiagnostics group, has reported a loss after tax of £5.79m, according to half year results for the six months ended 30 November 2019. This is almost £2m more than losses posted in the same period of 2018. Revenue did rise at the firm however, up to £0.31m from £0.12m, but Oncimmune was […]